Patents Assigned to Sienna Cancer Diagnostics Ltd
  • Patent number: 11391738
    Abstract: The disclosure provides methods for resolving an inconclusive cytological assessment of clinically relevant cells in a sample obtained from a patient based on the cytological detection of an antibody binding to a diagnostic protein in the clinically relevant cells in the sample.
    Type: Grant
    Filed: May 20, 2019
    Date of Patent: July 19, 2022
    Assignee: Sienna Cancer Diagnostics Ltd
    Inventors: Minesh Lalla, Fabio Turatti, Sharyn Wilson
  • Patent number: 10338072
    Abstract: The disclosure provides methods for resolving an inconclusive cytological assessment of clinically relevant cells in a sample obtained from a patient based on the cytological detection of antibody binding to telomerase in clinically relevant cells in the sample, wherein binding of the antibody to clinically relevant cells indicates the presence of malignant or cancerous cells.
    Type: Grant
    Filed: February 17, 2015
    Date of Patent: July 2, 2019
    Assignee: Sienna Cancer Diagnostics Ltd
    Inventors: Minesh Lalla, Fabio Turatti, Sharyn Wilson